Incident hepatitis C virus in women with human immunodeficiency virus infection

被引:15
作者
Augenbraun, M
Goedert, JJ
Thomas, D
Feldman, J
Seaberg, EC
French, AL
Robison, E
Nowicki, M
Terrault, N
机构
[1] SUNY Downstate Med Ctr, Brooklyn, NY 11203 USA
[2] Montefiore Med Ctr, Bronx, NY 10467 USA
[3] NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD USA
[4] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA
[5] Rush Med Coll, CORE Ctr, Cook Cty Hosp, Chicago, IL 60612 USA
[6] Univ So Calif, Los Angeles, CA USA
[7] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
10.1086/379075
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Individuals infected with human immunodeficiency virus type 1 (HIV-1) are frequently coinfected with hepatitis C virus (HCV). Acute HCV infection is often asymptomatic and poorly understood. We conducted a historical prospective study of HCV antibody and viremia in plasma samples obtained during 1994-1999 from a cohort of initially HIV-1-infected, HCV-uninfected women and from HIV-1-HCV-uninfected women. Twenty-two (1.5%) of 1517 experienced seroconversion. Of these, 14 (64%) truly acquired a new infection as assessed by enzyme immunoassay response and new-onset viremia. The incidence rate in HIV-1-infected women was 2.7 cases per 1000 person-years; it was 3.3 cases per 1000 person-years in HIV-1-seronegative women (relative risk, 1.21; P = .75). Acquisition of HCV was associated with any history of drug use (P < .01). Five of 12 viremic, seroconverting individuals cleared viremia. Incident HCV infection among HIV-1-infected and HIV-1-uninfected women was low. It was linked to drug use and commonly resolved.
引用
收藏
页码:1357 / 1364
页数:8
相关论文
共 30 条
[11]  
GARFEIN R, 1998, J ACQUIR IMMUNE D S1, V18, pS111
[12]   Prevention of HIV/AIDS and other blood-borne diseases among injection drug users - A national survey on the regulation of syringes and needles [J].
Gostin, LO ;
Lazzarini, Z ;
Jones, S ;
Flaherty, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (01) :53-62
[13]   The burden of hepatitis C in the United States [J].
Kim, WR .
HEPATOLOGY, 2002, 36 (05) :S30-S34
[14]   Hepatitis C in a hemodialysis unit: Molecular evidence for nosocomial transmission [J].
Le Pogam, S ;
Le Chapois, D ;
Christen, R ;
Dubois, F ;
Barin, F ;
Goudeau, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :3040-3043
[15]   HEPATITIS-C VIRUS-INFECTIONS IN TRANSPLANT PATIENTS - SEROLOGICAL AND VIROLOGICAL INVESTIGATIONS [J].
MAPLE, PAC ;
MCKEE, T ;
DESSELBERGER, U ;
WREGHITT, TG .
JOURNAL OF MEDICAL VIROLOGY, 1994, 44 (01) :43-48
[16]   Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders [J].
Messick, K ;
Sanders, JC ;
Goedert, JJ ;
Eyster, ME .
HAEMOPHILIA, 2001, 7 (06) :568-574
[17]   Predictors and risk-taking consequences of drug use among HIV-infected women [J].
Novotná, L ;
Wilson, TE ;
Minkoff, HL ;
McNutt, LA ;
DeHovitz, JA ;
Ehrlich, I ;
Des Jarlais, DC .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 20 (05) :502-507
[18]   Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests [J].
Schmidt, WN ;
Wu, P ;
Cederna, J ;
Mitros, FA ;
LaBrecque, DR ;
Stapleton, JT .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (01) :27-33
[19]  
Seeff Leonard B, 2003, Clin Liver Dis, V7, P261, DOI 10.1016/S1089-3261(02)00078-8
[20]   Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS clinical trials group [J].
Sherman, KE ;
Rouster, SD ;
Chung, RT ;
Rajicic, N .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :831-837